Central sleep apnea (CSA) is a sleep disorder that is less common than obstructive sleep apnea, but it does have some similarities. In the US, CSA is estimated to affect less than 1% of adults over 40 ...

The weight-loss drug Zepbound (tirzepatide) now has another major benefit: on Dec. 20, it became the first drug approved by the U.S. Food and Drug Administration (FDA) to treat obstructive sleep apnea ...

People living in areas of elevated air pollution may be at risk of more serious sleep apnea events, according to a large new study that spans multiple countries. However, being aware of your air ...

Everyone knows the feeling: tossing and turning during a hot, sticky night when sleep feels impossible. It's hard for anyone to sleep well when it's hot out. And the disruptions are growing, ...